This Blood Pressure Drug Is Very Dangerous
Treating high blood pressure is perhaps one of the most important things a person can do for their body. There are many drugs available on the market created for the purposes of treating high blood pressure. However, it's best to veer on the side of caution when it comes to certain blood pressure drugs. It may mean the difference between life and death.
In particular, there has been a recall drafted for the blood pressure drug valsartan. The Food and Drug Administration pulled Valsartan back due to a cancer-causing impurity called N-Nitrosodiethylamine (NDEA) that they found in quantities too high for human consumption.
For the time being, Aurobindo Pharma Ltd has recalled 80 lots of medicine to ensure the safety of their clientele. A lot of their medications that contains valsartan, which is at high risk of containing the NDEA carcinogen, have been recalled. It can't be risked for any of the medication to be overlooked due to the chance that it may contain the NDEA impurity.
Steering Clear Of NDEA
This resulted in a recall of any blood pressure drugs with NDEA in it, or at least valsartan that has amounts of NDEA that are unacceptably high.
The FDA will continue to investigate the problem by testing angiotensin II receptor blockers for any signs of NDEA that are too high. They will also test for any other possible carcinogens.
Continued FDA Investigation
While this is a frightening case, it is still being investigated by leading drug scientists and the FDA. The FDA, in fact, has stopped any imports of medicines or any drug ingredients produced at a factory that uses valsartan.
These are typically in bulk Chinese factories, namely the Zhejiang Huahai Pharmaceuticals. This ceases in the pharmaceutical drug import was established in October of the previous year and will hopefully be the solution to this problem.